Early and accurate recognition of dementia's warning signs is becoming increasingly crucial as experts highlight often-dismissed indicators that precede more commonly known symptoms. While primarily associated with older populations, the memory-robbing condition, which is projected to significantly rise globally, is now being linked to subtle changes in emotional and sensory processing.

Research from theUniversity of Cambridge and Tel Aviv Universitysuggests that an inability to correctly interpret others' emotions could be among the earliest indicators of cognitive decline, a precursor to dementia. A study involving over 600 older adults tasked them with an emotion recognition exercise, revealing that those experiencing cognitive decline were more prone to interpreting neutral or negative emotions, such as anger, fear, or sadness, as positive.

This 'positivity bias' was also correlated with observable changes in brain regions vital for emotional processing and their communication with areas involved in social decision-making, potentially reflecting neurodegeneration. Significantly, researchers noted a lack of association between this positivity bias and depression in old age, a finding that could help distinguish cognitive decline from depression, another key symptom of dementia.

Photo Credit: CNN

Beyond emotional cues, a decline in the sense of smell has been identified by researchers from the University of Florida (UF)as another early warning sign of Alzheimer's disease. Damage to the brain regions responsible for processing scents can occur even before the onset of more overt cognitive symptoms like memory loss or confusion, making olfactory changes a potential harbinger of the condition.

To assess this, UF researchers developed a simple DIY test utilizing a dollop of peanut butter and a ruler. Peanut butter was chosen as a 'pure odorant,' stimulating only the sense of smell without activating the trigeminal nerve. The test involves a patient closing their eyes and mouth and blocking one nostril, while a clinician gradually moves the peanut butter closer to the open nostril, noting the detection distance.

The procedure is then repeated for the other nostril after a 90-second delay. A key finding was that patients in the early stages of Alzheimer's often exhibited a dramatic difference between nostrils, with the left nostril detecting the smell at an average of 10 centimeters closer to the nose compared to the right. This specific left nostril impairment was not observed in patients with other forms of dementia.

Experts like Dr. David Sinclair of Harvard Medical School have lauded the peanut butter and ruler test as a 'simple and inexpensive yet effective' method for detecting early-stage Alzheimer's, explaining that the disease can unequally affect brain hemispheres and olfactory bulbs, leading to differential sensitivity between nostrils. While peanut butter may pose issues for those with nut allergies, other pure odorants such as anise, banana, mint, pine, chocolate, cinnamon, lemon, and onion can serve as alternatives. Furthermore, Mass General Brigham in Boston has developed other at-home olfactory tests involving sniffable odor labels on cards to assess discrimination, identification, and memory of scents.

Despite the promise of these tests for early detection, medical professionals, includingDr. Gayatri Deviof the Zucker School of Medicine, caution against self-diagnosis. She stresses that such tests should be performed 'within the proper context of a medical examination' to avoid unnecessary worry and stress for individuals concerned about brain health. DIY diagnoses for serious conditions like Alzheimer's are strongly discouraged given the gravity of the diagnosis.

Dementia and Alzheimer's represent a significant public health challenge. In the UK, approximately 900,000 individuals currently live with dementia, a figure projected to rise to 1.7 million within two decades, marking a 40 percent increase. In the United States, around 7 million people aged 65 and older are affected, with over 100,000 dying annually, and projections indicating nearly 13 million Americans will be living with the disease by 2050. Alzheimer's disease, the most common form of dementia, was responsible for 74,261 deaths in the UK in 2022, making it the country's biggest killer.

Photo Credit: Financial Times

The disease is fundamentally caused by the accumulation of toxic amyloid and tau proteins in the brain. Amyloid proteins form clumps called plaques, while tau proteins twist into fiber-like tangles. These plaques and tangles disrupt the brain's neural communication, leading to permanent damage and the progressive loss of vital functions, including speech, self-care, and responsiveness to the environment.

However, there is growing hope for prevention. A landmark study identified 14 lifestyle factors, including newly recognized risk factors like high cholesterol and vision loss, that, when addressed from childhood, could prevent almost half of allAlzheimer'scases globally. These factors, alongside existing ones like genetics and smoking status, offer a comprehensive approach to mitigating the risk of this devastating disorder.